메뉴 바로가기
주메뉴 바로가기
컨텐츠 바로가기

참여교수 및 연구

  • 참여교수 및 연구
  • 참여교수 개별소개

참여교수 개별소개

박종휘, Ph.D.
소속 및 직위
소속: 생명과학과 , 직위: 조교수
실험실명
NeuOnc (신경종양 연구실)
연구분야
항암치료기전/후성유전학/세포신호전달
연구실위치
암당뇨연구원 N405호
전공분야
신경과학/종양생물학
  • +82-32-899-6115
  • jpark@gachon.ac.kr
  • https://lab.researchwho.com/neuonc/

 학력 및 경력

2007 학사, 고려대학교

2014 석사, FAU Erlangen-Nürnberg, Germany
2018 박사, Medical University of Innsbruck, Austria

2018-2020 박사후 연구원, Heidelberg University Hospital, Germany
2020-2021 박사후 연구원, Stanford University, USA
2022-현재 조교수, 가천대학교



■ 최근 연구업적(2018-현재)

 

2023 | Jagged1 intracellular domain/SMAD3 complex transcriptionally regulates TWIST1 to drive glioma invasion. Cell Death & Disease. (IF=9, Co-corresponding author)


2023 | Annexin A2 Stabilizes Oncogenic JAG1 Intracellular Domain by Inhibiting Proteasomal Degradation in Glioblastoma Cells. International Journal of Molecular Sciences. (IF=5.6, Co-corresponding author)


2023 | CIC Reduces xCT/SLC7A11 Expression and Glutamate Release in Glioma. Acta Neuropathologica Communications. (IF=7.1, Co-corresponding author)


2023 | Metabolic Rewiring in Adult-Type Diffuse Gliomas. International Journal of Molecular Sciences. (IF=5.6, Corresponding author)


2023 | Clinically relevant concurrent BRAF and MEK inhibition alters differentiation states and sensitizes BRAF V600E-mutated high-grade gliomas to immune checkpoint blockade. (bioRxiv, First author)


2022 | MEOX2 homeobox gene promotes growth of malignant gliomas. Neuro-Oncology. (IF=15.9)


2021 | TERT and DNMT1 Expression Predict Sensitivity to Decitabine in Gliomas. Neuro-Oncology. (IF=15.9, First author)


2019 | Single-nucleus chromatin accessibility reveals intratumoral epigenetic heterogeneity in IDH1 mutant gliomas. Acta Neuropathologica Communications. (IF=7.1)


2019 | Epigenetic Reprogramming for Targeting IDH-Mutant Malignant Gliomas. Cancers. (IF=5.2, First author)


2019 | Subcellular localization of Sprouty2 in human glioma cells. Frontiers in Molecular Neuroscience. (IF=4.8)


2018 | Sprouty2 Enhances the Tumorigenic Potential of Glioblastoma Cells. Neuro-Oncology. (IF=15.9, First author)